Clinical outcome of deep brain stimulation for Parkinson's disease

Handbook of Clinical Neurology

Volumn 116, Issue , 2013, Pages 107-128

  Deuschl, Günther ^a   Paschen, Steffen ^a   Witt, Karsten ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Deep brain stimulation; Motor symptoms; Nonmotor symptoms; Parkinson; Selection criteria; Side effects; Targets for DBS

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; HUMAN; METHODOLOGY; MOTOR SYMPTOMS; NONMOTOR SYMPTOMS; PARKINSON; PARKINSON DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELECTION CRITERIA; SIDE-EFFECTS; TARGETS FOR DBS; TREATMENT OUTCOME;

DEEP BRAIN STIMULATION; MOTOR SYMPTOMS; NONMOTOR SYMPTOMS; PARKINSON; SELECTION CRITERIA; SIDE-EFFECTS; TARGETS FOR DBS;

DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84885087552     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53497-2.00010-3     Document Type: Chapter

References (172)

1. Allert N., Lehrke R., Sturm V., et al. Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson's disease. J Neural Transm 2010, 117:349-351.
2. Anderson V.C., Burchiel K.J., Hogarth P., et al. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005, 62:554-560.
3. Antonini A., Pilleri M., Padoan A., et al. Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene. J Neurol 2012, 259:165-167.
4. Arai E., Arai M., Uchiyama T., et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain 2012, 135:1478-1485.
5. Ardouin C., Pillon B., Peiffer E., et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999, 46:217-223.
6. Ardouin C., Voon V., Worbe Y., et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006, 21:1941-1946.
7. Arnulf I., Bejjani B.P., Garma L., et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55:1732-1734.
8. Arnulf I., Bejjani B.P., Garma L., et al. Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor. J Sleep Res 2000, 9:55-62.
9. Aron A.R., Poldrack R.A. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J Neurosci 2006, 26:2424-2433.
10. Bakker M., Esselink R.A., Munneke M., et al. Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease. Mov Disord 2004, 19:1092-1099.
11. Ballanger B., van Eimeren T., Moro E., et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009, 66:817-824.
12. Bannier S., Montaurier C., Derost P.P., et al. Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up. J Neurol Neurosurg Psychiatry 2009, 80:484-488.
13. Barichella M., Marczewska A.M., Mariani C., et al. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Mov Disord 2003, 18:1337-1340.
14. Barone P., Antonini A., Colosimo C., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24:1641-1649.
15. Barone P., Poewe W., Albrecht S., et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:573-580.
16. Bejjani B.P., Damier P., Arnulf I., et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999, 340:1476-1480.
17. Blomstedt P., Bjartmarz H. Intracerebral infections as a complication of deep brain stimulation. Stereotact Funct Neurosurg 2012, 90:92-96.
18. Braak H., Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 2008, 70:1916-1925.
19. Breit S., Wachter T., Schmid-Bielenberg D., et al. Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease. J Neurol 2010, 257:1205-1207.
20. Brice J., McLellan L. Suppression of intention tremor by contingent deep-brain stimulation. Lancet 1980, 1:1221-1222.
21. Broen M., Duits A., Visser-Vandewalle V., et al. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011, 17:413-417.
22. Bronner G., Royter V., Korczyn A.D., et al. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 2004, 30:95-105.
23. Burdick A.P., Foote K.D., Wu S., et al. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation. Neuroimage 2011, 54:S227-S232.
24. Castelli L., Perozzo P., Genesia M.L., et al. Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2004, 75:1260-1264.
25. Castelli L., Rizzi L., Zibetti M., et al. Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study. Parkinsonism Relat Disord 2010, 16:115-118.
26. Castrioto A., Lozano A.M., Poon Y.Y., et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011, 68:1550-1556.
27. Chahine L.M., Ahmed A., Sun Z. Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. Parkinsonism Relat Disord 2011, 17:208-211.
28. Charles P.D., Van Blercom N., Krack P., et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002, 59:932-934.
29. Charles P.D., Dolhun R.M., Gill C.E., et al. Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial. Parkinsonism Relat Disord 2012, 18:268-273.
30. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245.
31. Contarino M.F., Daniele A., Sibilia A.H., et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:248-252.
32. Czernecki V., Schüpbach M., Yaici S., et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 2008, 23:964-969.
33. Daniele A., Albanese A., Contarino M.F., et al. Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003, 74:175-182.
34. Daniels C., Krack P., Volkmann J., et al. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2010, 25:1583-1589.
35. Daniels C., Krack P., Volkmann J., et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?. Mov Disord 2011, 26:2516-2521.
36. Deep-Brain Stimulation for Parkinson's Disease Study Group Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001, 345:956-963.
37. Deuschl G., Agid Y. Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits. Lancet Neurol 2013, 12:1025-1034.
38. Deuschl G., Herzog J., Kleiner-Fisman G., et al. Deep brain stimulation: postoperative issues. Mov Disord 2006, 21:S219-S237.
39. Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006, 355:896-908.
40. Deuschl G., Schüpbach M., Knudsen K., et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord 2013, 19:56-61.
41. Djaldetti R., Baron J., Ziv I., et al. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996, 46:1051-1054.
42. Evidente V.G., Lyons M.K., Wheeler M., et al. First case of X-linked dystonia-parkinsonism ("Lubag") to demonstrate a response to bilateral pallidal stimulation. Mov Disord 2007, 22:1790-1793.
43. Fahn S., Elton R.L. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's disease 1987, 153-163. MacMillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D. Calne (Eds.).
44. Fasano A., Romito L.M., Daniele A., et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010, 133:2664-2676.
45. Fasano A., Daniele A., Albanese A. Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol 2012, 11:429-442.
46. Ferraye M.U., Debu B., Fraix V., et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010, 133:205-214.
47. Follett K.A., Weaver F.M., Stern M., et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010, 362:2077-2091.
48. Fox S.H., Katzenschlager R., Lim S.Y., et al. The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011, 26:S2-S41.
49. Frank M.J., Samanta J., Moustafa A.A., et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007, 318:1309-1312.
50. Friedman J.H. Punding on levodopa. Biol Psychiatry 1994, 36:350-351.
51. Fritsche H.M., Ganzer R., Schlaier J., et al. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Mov Disord 2009, 24:1553-1554.
52. Gallagher D.A., Lees A.J., Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?. Mov Disord 2010, 25:2493-2500.
53. Gentil M., Pinto S., Pollak P., et al. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang 2003, 85:190-196.
54. Gervais-Bernard H., Xie-Brustolin J., Mertens P., et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009, 256:225-233.
55. Gierthmuhlen J., Arning P., Binder A., et al. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 2010, 25:1195-1202.
56. Giovannoni G., O'Sullivan J.D., Turner K., et al. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000, 68:423-428.
57. Global Parkinson's Disease Survey Steering Committee Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002, 17:60-67.
58. Halbig T.D., Tse W., Frisina P.G., et al. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. Eur J Neurol 2009, 16:493-497.
59. Hamani C., Richter E., Schwalb J.M., et al. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2005, 56:1313-1321.
60. Hardoff R., Sula M., Tamir A., et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001, 16:1041-1047.
61. Hariz M.I. What is deep brain stimulation "failure" and how do we manage our own failures?. Arch Neurol 2005, 62:1938.
62. Hariz G.M., Blomstedt P., Koskinen L.O. Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life. Acta Neurol Scand 2008, 118:387-394.
63. Hershey T., Revilla F.J., Wernle A., et al. Stimulation of STN impairs aspects of cognitive control in PD. Neurology 2004, 62:1110-1114.
64. Herzog J., Reiff J., Krack P., et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord 2003, 18:1382-1384.
65. Herzog J., Weiss P.H., Assmus A., et al. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. Brain 2006, 129:3366-3375.
66. Herzog J., Pinsker M., Wasner M., et al. Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 2007, 22:679-684.
67. Herzog J., Weiss P.H., Assmus A., et al. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 2008, 131:132-145.
68. Hjort N., Ostergaard K., Dupont E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004, 19:196-199.
69. Iranzo A., Valldeoriola F., Santamaria J., et al. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:661-664.
70. Jahanshahi M., Ardouin C.M., Brown R.G., et al. The impact of deep brain stimulation on executive function in Parkinson's disease. Brain 2000, 123:1142-1154.
71. Johansen K.K., Jorgensen J.V., White L.R., et al. Parkinson-related genetics in patients treated with deep brain stimulation. Acta Neurol Scand 2008, 123:201-206.
72. Kahn E., D'Haese P.F., Dawant B., et al. Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry 2012, 83:164-170.
73. Kaiser I., Kryspin-Exner I., Brucke T., et al. Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up. BMC Neurol 2008, 8:43.
74. Kedia S., Moro E., Tagliati M., et al. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004, 63:2410-2412.
75. Kim H.J., Paek S.H., Kim J.Y., et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 2008, 255:1889-1894.
76. Kim H.J., Jeon B.S., Paek S.H. Effect of deep brain stimulation on pain in Parkinson disease. J Neurol Sci 2011, 310:251-255.
77. Kimmelman J., Duckworth K., Ramsay T., et al. Risk of surgical delivery to deep nuclei: a meta-analysis. Mov Disord 2011, 26:1415-1421.
78. Kleiner-Fisman G., Herzog J., Fisman D.N., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006, 21:S290-S304.
79. Klockgether T., Borutta M., Rapp H., et al. A defect of kinesthesia in Parkinson's disease. Mov Disord 1995, 10:460-465.
80. Klotsche J., Reese J.P., Winter Y., et al. Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study. Value Health 2011, 14:329-338.
81. Krack P., Pollak P., Limousin P., et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998, 43:180-192.
82. Krack P., Pollak P., Limousin P., et al. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain 1999, 122:1133-1146.
83. Krack P., Batir A., Van Blercom N., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934.
84. Krack P., Hariz M.I., Baunez C., et al. Deep brain stimulation: from neurology to psychiatry?. Trends Neurosci 2010, 33:474-484.
85. Krauss J.K., Pohle T., Weigel R., et al. Deep brain stimulation of the centre median-parafascicular complex in patients with movement disorders. J Neurol Neurosurg Psychiatry 2002, 72:546-548.
86. Lang A.E., Houeto J.L., Krack P., et al. Deep brain stimulation: preoperative issues. Mov Disord 2006, 21:S171-S196.
87. Lewis G.N., Byblow W.D. Altered sensorimotor integration in Parkinson's disease. Brain 2002, 125:2089-2099.
88. Lhommée E., Klinger H., Thobois S., et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain 2012, 135:1463-1477.
89. Lim S.Y., O'Sullivan S.S., Kotschet K., et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009, 16:1148-1152.
90. Loher T.J., Burgunder J.M., Pohle T., et al. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg 2002, 96:844-853.
91. Ludwig J., Remien P., Guballa C., et al. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:742-745.
92. Lyons K.E., Pahwa R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg 2006, 104:502-505.
93. Maier C., Baron R., Tölle T.R., et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010, 150:439-450.
94. Mallet L., Schüpbach M., N'Diaye K., et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A 2007, 104:10661-10666.
95. Martinez-Martin P. An introduction to the concept of "quality of life in Parkinson's disease". J Neurol 1998, 245:S2-S6.
96. Martinez-Martin P., Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Mov Disord 2007, 22:757-765.
97. Martinez-Martin P., Jeukens-Visser M., Lyons K.E., et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord 2011, 26:2371-2380.
98. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric Psychiatry 1976, 77-121. Grune and Stratton, New York. L. Bellak, T. Karatsu (Eds.).
99. Maurer C., Mergner T., Xie J., et al. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain 2003, 126:1146-1163.
100. Mazzone P., Lozano A., Stanzione P., et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. NeuroReport 2005, 16:1877-1881.
101. Merola A., Zibetti M., Angrisano S., et al. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 2011, 134:2074-2084.
102. Miyawaki E., Perlmutter J.S., Troster A.I., et al. The behavioral complications of pallidal stimulation: a case report. Brain Cogn 2000, 42:417-434.
103. Monaca C., Ozsancak C., Jacquesson J.M., et al. Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease. J Neurol 2004, 251:214-218.
104. Montaurier C., Morio B., Bannier S., et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain 2007, 130:1808-1818.
105. Moreau C., Defebvre L., Devos D., et al. STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach?. Mov Disord 2009, 24:2164-2166.
106. Moro E., Volkmann J., Konig I.R., et al. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology 2008, 70:1186-1191.
107. Moro E., Lozano A.M., Pollak P., et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010, 25:578-586.
108. Odekerken V.J., van Laar T., Staal M.J., et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013, 12:37-44.
109. Okai D., Samuel M., Askey-Jones S., et al. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework. Eur J Neurol 2011, 18:1379-1383.
110. Okun M.S., Tagliati M., Pourfar M., et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005, 62:1250-1255.
111. Okun M.S., Fernandez H.H., Wu S.S., et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009, 65:586-595.
112. Okun M.S., Gallo B.V., Mandybur G., et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012, 11:140-149.
113. Parsons T.D., Rogers S.A., Braaten A.J., et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006, 5:578-588.
114. Piboolnurak P., Lang A.E., Lozano A.M., et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007, 22:990-997.
115. Pinto S., Thobois S., Costes N., et al. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study. Brain 2004, 127:602-615.
116. Plaha P., Ben-Shlomo Y., Patel N.K., et al. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006, 129:1732-1747.
117. Plaha P., Khan S., Gill S.S. Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry 2008, 79:504-513.
118. Rieu I., Derost P., Ulla M., et al. Body weight gain and deep brain stimulation. J Neurol Sci 2011, 310:267-270.
119. Rodriguez-Oroz M.C., Obeso J.A., Lang A.E., et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005, 128:2240-2249.
120. Romito L.M., Contarino M.F., Vanacore N., et al. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 2009, 24:557-563.
121. Rouaud T., Dondaine T., Drapier S., et al. Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation. Mov Disord 2010, 25:1839-1846.
122. Saint-Cyr J.A., Trepanier L.L., Kumar R., et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000, 123:2091-2108.
123. Sauleau P., Leray E., Rouaud T., et al. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease. Mov Disord 2009, 24:2149-2155.
124. Schuepbach W.M., Rau J., Knudsen K., et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013, 368:610-622.
125. Schüpbach W.M., Chastan N., Welter M.L., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005, 76:1640-1644.
126. Schüpbach M., Lohmann E., Anheim M., et al. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord 2007, 22:119-122.
127. Schüpbach W.M., Maltete D., Houeto J.L., et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007, 68:267-271.
128. Seif C., Herzog J., van der Horst C., et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004, 55:118-120.
129. Shohamy D. Learning and motivation in the human striatum. Curr Opin Neurobiol 2011, 21:408-414.
130. Simonin C., Tir M., Devos D., et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol 2009, 256:1736-1741.
131. Smeding H.M., Goudriaan A.E., Foncke E.M., et al. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 2007, 78:517-519.
132. Smeding H.M., Speelman J.D., Huizenga H.M., et al. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry 2011, 82:754-760.
133. St George R.J., Nutt J.G., Burchiel K.J., et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 2010, 75:1292-1299.
134. Stefani A., Lozano A.M., Peppe A., et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007, 130:1596-1607.
135. Stolze H., Klebe S., Poepping M., et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology 2001, 57:144-146.
136. Strowd R.E., Cartwright M.S., Passmore L.V., et al. Weight change following deep brain stimulation for movement disorders. J Neurol 2010, 257:1293-1297.
137. Tanner C.M. A second honeymoon for Parkinson's disease?. N Engl J Med 2013, 368:675-676.
138. Tarsy D., Scollins L., Corapi K., et al. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor. Stereotact Funct Neurosurg 2005, 83:222-227.
139. Temel Y., Kessels A., Tan S., et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006, 12:265-272.
140. Thobois S., Ardouin C., Lhommée E., et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010, 133:1111-1127.
141. Trachani E., Constantoyannis C., Sakellaropoulos G.C., et al. Heart rate variability in Parkinson's disease unaffected by deep brain stimulation. Acta Neurol Scand 2012, 126:56-61.
142. Tripoliti E., Zrinzo L., Martinez-Torres I., et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 2011, 76:80-86.
143. Umemura A., Oka Y., Okita K., et al. Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions. J Neurosurg 2011, 114:1701-1705.
144. van den Wildenberg W.P., van Boxtel G.J., van der Molen M.W., et al. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J Cogn Neurosci 2006, 18:626-636.
145. Videnovic A., Metman L.V. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008, 23:343-349.
146. Voges J., Hilker R., Botzel K., et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord 2007, 22:1486-1489.
147. Volkmann J., Deuschl G. Deep brain stimulation. Handb Clin Neurol 2007, 84:261-277.
148. Volkmann J., Allert N., Voges J., et al. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004, 55:871-875.
149. Volkmann J., Albanese A., Kulisevsky J., et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009, 24:1154-1161.
150. Volkmann J., Daniels C., Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010, 6:487-498.
151. Voon V., Kubu C., Krack P., et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006, 21:S305-S327.
152. Voon V., Krack P., Lang A.E., et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
153. Wadia P.M., Lim S.Y., Lozano A.M., et al. Bilateral pallidal stimulation for x-linked dystonia parkinsonism. Arch Neurol 2011, 67:1012-1015.
154. Wasner G., Deuschl G. Pains in Parkinson disease - many syndromes under one umbrella. Nat Rev Neurol 2012, 8:284-294.
155. Weaver F.M., Follett K., Stern M., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009, 301:63-73.
156. Weaver F.M., Follett K.A., Stern M., et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012, 79:55-65.
157. Weintraub D., Koester J., Potenza M.N., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
158. Wider C., Pollo C., Bloch J., et al. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008, 14:114-119.
159. Williams A., Gill S., Varma T., et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010, 9:581-591.
160. Williams A.E., Arzola G.M., Strutt A.M., et al. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord 2011, 17:321-327.
161. Winge K., Nielsen K.K., Stimpel H., et al. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus. Mov Disord 2007, 22:220-225.
162. Witjas T., Baunez C., Henry J.M., et al. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation. Mov Disord 2005, 20:1052-1055.
163. Witjas T., Kaphan E., Regis J., et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007, 22:1729-1734.
164. Witt K., Pulkowski U., Herzog J., et al. Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch Neurol 2004, 61:697-700.
165. Witt K., Daniels C., Reiff J., et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008, 7:605-614.
166. Witt K., Granert O., Daniels C., et al. Relation of lead location trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain 2013, 136:2109-2119.
167. Woods S.P., Fields J.A., Lyons K.E., et al. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up. Acta Neurochir (Wien) 2001, 143:1273-1277.
168. York M.K., Wilde E.A., Simpson R., et al. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci 2009, 287:159-171.
169. Yoshida F., Miyagi Y., Kishimoto J., et al. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients. Stereotact Funct Neurosurg 2009, 87:45-49.
170. Zangaglia R., Pacchetti C., Pasotti C., et al. Deep brain stimulation and cognitive functions in Parkinson's disease: a three-year controlled study. Mov Disord 2009, 24:1621-1628.
171. Zibetti M., Torre E., Cinquepalmi A., et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007, 58:218-223.
172. Zibetti M., Merola A., Rizzi L., et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord 2011, 26:2327-2334.